Matthew M Klairmont (M M Klairmont)

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 6

Top Topics

Chronic Myeloid Leukemia

Diffuse Large B Cell Lymphoma

Network Analysis

Top Venues

Pediatric blood & cancer

Leukemia & lymphoma

International journal of laboratory hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Tauangtham Anekpuritanang, Matthew M Klairmont, Joel Gradowski, Kohei Hagiwara, Nathanael G Bailey, Pranil Chandra, Yiwei Liu, Heather L Mulder, John Easton, Jinghui Zhang, Michael G Martin, Anna B Owczarczyk, Jennifer B Dunlap, Guang Fan, Richard D Press, Philipp W Raess
In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported. Blood advances 5 (23) (2022)
Matthew M Klairmont, Nicholas Ward
Co-occurring rearrangements of DUSP22 and TP63 define a rare genetic subset of ALK-negative anaplastic large cell lymphoma with inferior survival outcomes. Leukemia & lymphoma (2021)
Richa Sharma, Matthew M Klairmont, Ashley C Holland, John K Choi, Charles G Mullighan, Lu Wang, John T Sandlund, Ching-Hong Pui, Hiroto Inaba
Integrative genomic analysis of B-lymphoblastic lymphoma with intrachromosomal amplification of chromosome 21. Pediatric blood & cancer 67 (9) (2020)
Matthew M Klairmont, John Kim Choi
Mixed-phenotype acute leukemia, T/megakaryoblastic. Blood 132 (22) (2019)
Jinjun Cheng, Matthew M Klairmont, John K Choi
Peripheral blood flow cytometry for the diagnosis of pediatric acute leukemia: Highly reliable with rare exceptions. Pediatric blood & cancer 66 (1) (2018)
Matthew M Klairmont, J Cheng, L Schwartzberg, H H Ho, J F Gradowski
Chronic myeloid leukemia, BCR-ABL1-positive with CALR and MPL mutations. International journal of laboratory hematology 40 (3) (2018)